The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Bordetella Vaccine Market Research Report 2025
Synopsis
Global Oral Bordetella Vaccine market is projected to reach US$ 444.9 million in 2029, increasing from US$ 125 million in 2022, with the CAGR of 19.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Bordetella Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Bordetella Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boehringer Ingelheim(Merial)
Merck Animal Health
Zoetis
Elanco
Segment by Type
Combination Vaccine
Only Bordetella Vaccine
Segment by Application
Puppies
Adult Dogs
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Bordetella Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Oral Bordetella Vaccine market is projected to reach US$ 444.9 million in 2029, increasing from US$ 125 million in 2022, with the CAGR of 19.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Bordetella Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Bordetella Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boehringer Ingelheim(Merial)
Merck Animal Health
Zoetis
Elanco
Segment by Type
Combination Vaccine
Only Bordetella Vaccine
Segment by Application
Puppies
Adult Dogs
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Oral Bordetella Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Oral Bordetella Vaccine Market Overview
1.1 Product Overview and Scope of Oral Bordetella Vaccine
1.2 Oral Bordetella Vaccine Segment by Type
1.2.1 Global Oral Bordetella Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Combination Vaccine
1.2.3 Only Bordetella Vaccine
1.3 Oral Bordetella Vaccine Segment by Application
1.3.1 Global Oral Bordetella Vaccine Market Value by Application: (2023-2029)
1.3.2 Puppies
1.3.3 Adult Dogs
1.4 Global Oral Bordetella Vaccine Market Size Estimates and Forecasts
1.4.1 Global Oral Bordetella Vaccine Revenue 2018-2029
1.4.2 Global Oral Bordetella Vaccine Sales 2018-2029
1.4.3 Global Oral Bordetella Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oral Bordetella Vaccine Market Competition by Manufacturers
2.1 Global Oral Bordetella Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oral Bordetella Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oral Bordetella Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Oral Bordetella Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oral Bordetella Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Bordetella Vaccine, Product Type & Application
2.7 Oral Bordetella Vaccine Market Competitive Situation and Trends
2.7.1 Oral Bordetella Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Bordetella Vaccine Players Market Share by Revenue
2.7.3 Global Oral Bordetella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Bordetella Vaccine Retrospective Market Scenario by Region
3.1 Global Oral Bordetella Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oral Bordetella Vaccine Global Oral Bordetella Vaccine Sales by Region: 2018-2029
3.2.1 Global Oral Bordetella Vaccine Sales by Region: 2018-2023
3.2.2 Global Oral Bordetella Vaccine Sales by Region: 2024-2029
3.3 Global Oral Bordetella Vaccine Global Oral Bordetella Vaccine Revenue by Region: 2018-2029
3.3.1 Global Oral Bordetella Vaccine Revenue by Region: 2018-2023
3.3.2 Global Oral Bordetella Vaccine Revenue by Region: 2024-2029
3.4 North America Oral Bordetella Vaccine Market Facts & Figures by Country
3.4.1 North America Oral Bordetella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oral Bordetella Vaccine Sales by Country (2018-2029)
3.4.3 North America Oral Bordetella Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Bordetella Vaccine Market Facts & Figures by Country
3.5.1 Europe Oral Bordetella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oral Bordetella Vaccine Sales by Country (2018-2029)
3.5.3 Europe Oral Bordetella Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Bordetella Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Bordetella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oral Bordetella Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Oral Bordetella Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Bordetella Vaccine Market Facts & Figures by Country
3.7.1 Latin America Oral Bordetella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oral Bordetella Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Oral Bordetella Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Bordetella Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Bordetella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oral Bordetella Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oral Bordetella Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Bordetella Vaccine Sales by Type (2018-2029)
4.1.1 Global Oral Bordetella Vaccine Sales by Type (2018-2023)
4.1.2 Global Oral Bordetella Vaccine Sales by Type (2024-2029)
4.1.3 Global Oral Bordetella Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Oral Bordetella Vaccine Revenue by Type (2018-2029)
4.2.1 Global Oral Bordetella Vaccine Revenue by Type (2018-2023)
4.2.2 Global Oral Bordetella Vaccine Revenue by Type (2024-2029)
4.2.3 Global Oral Bordetella Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Oral Bordetella Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oral Bordetella Vaccine Sales by Application (2018-2029)
5.1.1 Global Oral Bordetella Vaccine Sales by Application (2018-2023)
5.1.2 Global Oral Bordetella Vaccine Sales by Application (2024-2029)
5.1.3 Global Oral Bordetella Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Oral Bordetella Vaccine Revenue by Application (2018-2029)
5.2.1 Global Oral Bordetella Vaccine Revenue by Application (2018-2023)
5.2.2 Global Oral Bordetella Vaccine Revenue by Application (2024-2029)
5.2.3 Global Oral Bordetella Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Oral Bordetella Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Boehringer Ingelheim(Merial)
6.1.1 Boehringer Ingelheim(Merial) Corporation Information
6.1.2 Boehringer Ingelheim(Merial) Description and Business Overview
6.1.3 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Product Portfolio
6.1.5 Boehringer Ingelheim(Merial) Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Corporation Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Oral Bordetella Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Animal Health Oral Bordetella Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Oral Bordetella Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Zoetis Oral Bordetella Vaccine Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Oral Bordetella Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elanco Oral Bordetella Vaccine Product Portfolio
6.4.5 Elanco Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Bordetella Vaccine Industry Chain Analysis
7.2 Oral Bordetella Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Bordetella Vaccine Production Mode & Process
7.4 Oral Bordetella Vaccine Sales and Marketing
7.4.1 Oral Bordetella Vaccine Sales Channels
7.4.2 Oral Bordetella Vaccine Distributors
7.5 Oral Bordetella Vaccine Customers
8 Oral Bordetella Vaccine Market Dynamics
8.1 Oral Bordetella Vaccine Industry Trends
8.2 Oral Bordetella Vaccine Market Drivers
8.3 Oral Bordetella Vaccine Market Challenges
8.4 Oral Bordetella Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
